MicroTech Medical Hangzhou Co Ltd
HKEX:2235

Watchlist Manager
MicroTech Medical Hangzhou Co Ltd Logo
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Watchlist
Price: 5.96 HKD -3.25% Market Closed
Market Cap: 2.5B HKD

Operating Margin
MicroTech Medical Hangzhou Co Ltd

-66.9%
Current
-64%
Average
4.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-66.9%
=
Operating Profit
-196.2m
/
Revenue
293.2m

Operating Margin Across Competitors

MicroTech Medical Hangzhou Co Ltd
Glance View

Market Cap
2.5B HKD
Industry
Health Care

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.

Intrinsic Value
2.88 HKD
Overvaluation 52%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-66.9%
=
Operating Profit
-196.2m
/
Revenue
293.2m
What is the Operating Margin of MicroTech Medical Hangzhou Co Ltd?

Based on MicroTech Medical Hangzhou Co Ltd's most recent financial statements, the company has Operating Margin of -66.9%.

Back to Top